Results 1 to 10 of about 42,119 (250)

Amiodarone use prior to cardiac transplant in children is associated with increased need for post-transplant chronotropic support [PDF]

JHLT Open
Background: The use of amiodarone prior to cardiac transplant in adults is associated with worse post-transplant outcomes. Data are scarce in pediatrics regarding the association of pre-amiodarone use with post-transplant outcomes. We aim to describe and
Melodie M. Lynn, DO, Alexander Alali, MD, Timothy J. Humlicek, RPH, Kyle D. Hope, MD, Kriti Puri, MBBS, Taylor S. Howard, MD, Tam Dan Pham, MD, Hari P. Tunuguntla, MD, Swati Choudhry, MD, Christina Y. Miyake, MD, Santiago O. Valdes, MD, Jack F. Price, MD, Susan W. Denfield, MD, William J. Dreyer, MD, Jeffery J. Kim, MD, Joseph A. Spinner, MD   +15 more
doaj   +2 more sources

Prophylactic effect of Amiodarone and in combination with vitamin C in reducing atrial fibrillation after coronary artery bypass

European Journal of Translational Myology, 2021
Atrial fibrillation (AF) is the most common arrhythmia following cardiac surgery, leading to hemodynamic impairment and increased mortality and morbidity after coronary artery bypass grafting (CABG) and increases hospitalization.
Alireza Kamali, Samira Yavari, Bijan Yazdi, Alireza Rostami   +3 more
doaj   +1 more source

The Interaction of Amiodarone and Continuous-flow Left Ventricular Assist Device Use in Risk of Severe Primary Graft Dysfunction Following Heart Transplantation

Transplantation Direct, 2022
Background. Primary graft dysfunction (PGD) increases morbidity and mortality after heart transplant. Here we investigated (1) the association of continuous-flow left ventricular assist device (CF-LVAD), amiodarone, and severe PGD and (2) the safety of ...
Thiru Chinnadurai, MD, Snehal R. Patel, MD, Omar Saeed, MD, Waqas Hanif, MD, Mercedes Rivas-Lasarte, MD, PhD, Muhammad Farooq, MD, Carolyne Castillo, BSN, RN, Maria Taveras, BSN, RN, Daphenie Fauvel, FNP-BC, Jooyoung J. Shin, MD, Daniel Sims, MD, Sandhya Murthy, MD, Sasha Vukelic, MD, PhD, Patricia Chavez, MD, Stephen Forest, MD, Daniel Goldstein, MD, Ulrich P. Jorde, MD   +16 more
doaj   +1 more source

A multicenter retrospective cohort study on predicting the risk for amiodarone pulmonary toxicity

BMC Pulmonary Medicine, 2022
Background Amiodarone is one of the most commonly used anti-arrhythmic agents. Amiodarone pulmonary toxicity is a potentially fatal adverse effect associated with amiodarone use.
Wang Chun Kwok, Ting Fung Ma, Johnny Wai Man Chan, Herbert H. Pang, James Chung Man Ho   +4 more
doaj   +1 more source

Effect of Amiodarone and Hypothermia on Arrhythmia Substrates During Resuscitation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Amiodarone is administered during resuscitation, but its antiarrhythmic effects during targeted temperature management are unknown. The purpose of this study was to determine the effect of both therapeutic hypothermia and amiodarone on ...
Joseph S. Piktel, Yi Suen, Shalen Kouk, Danielle Maleski, Gary Pawlowski, Kenneth R. Laurita, Lance D. Wilson   +6 more
doaj   +1 more source

Amiodarone Hepatotoxicity [PDF]

Digestive Diseases, 2008
Potential hepatotoxicity related to amiodarone therapy is often a concern when deciding whether to initiate or continue treatment with this medication. While mostly associated with long-term oral administration of the drug, toxicity has also been reported early during intravenous administration and months after discontinuation of therapy.
S A, Josephson, E R, Kessel
openaire   +4 more sources

Efficacy of statins combined with amiodarone in the treatment of atrial fibrillation: A meta-analysis

European Journal of Inflammation, 2022
Objectives: Atrial fibrillation (AF) is a common arrhythmia in clinics with a high mortality rate. Recently, statins combined with amiodarone and amiodarone alone were used in the treatment of AF.
Yingbiao Wu, Xi Zhu, Zhongping Ning
doaj   +1 more source

Risk factors for amiodarone-induced thyroid dysfunction in Japan

Journal of Arrhythmia, 2016
Background: Amiodarone is associated with a number of significant adverse effects, including elevated transaminase levels, pulmonary fibrosis, arrhythmia, and thyroid dysfunction.
Sayoko Kinoshita, Tomohiro Hayashi, Kyoichi Wada, Mikie Yamato, Takeshi Kuwahara, Toshihisa Anzai, Mai Fujimoto, Kouichi Hosomi, Mitsutaka Takada   +8 more
doaj   +1 more source

Impaired Pharmacokinetics of Amiodarone under Veno-Venous Extracorporeal Membrane Oxygenation: From Bench to Bedside

Pharmaceutics, 2022
Background: Adjusting drug therapy under veno-venous extracorporeal membrane oxygenation (VV ECMO) is challenging. Although impaired pharmacokinetics (PK) under VV ECMO have been reported for sedative drugs and antibiotics, data about amiodarone are ...
Mickaël Lescroart, Claire Pressiat, Benjamin Péquignot, N’Guyen Tran, Jean-Louis Hébert, Nassib Alsagheer, Nicolas Gambier, Bijan Ghaleh, Julien Scala-Bertola, Bruno Levy   +9 more
doaj   +1 more source

CASE STUDY EFFECTIVNESS OF AMYODARON USE IN PATIENTS WITH SUPRAVENTRICULAR TACHYCARDIA AND HYPOTHYROIDISM

Medical and Health Science Journal, 2019
A woman, 53 years of age, with recurrent supraventricular tachycardia (SVT) with hypothyroidism was thought to be associated with amiodarone use. Patients repeatedly get amiodarone for their arrhythmias, where amiodarone has a broad antiarrhythmic
,Ardyarini Dyah Savitri
doaj   +1 more source